An oral drug for the treatment of advanced melanoma in patients with BRAF V600E and V600K mutations.
If you have a Hayes login, click here to view the full report on the Knowledge Center.
An oral drug for the treatment of advanced melanoma in patients with BRAF V600E and V600K mutations.
If you have a Hayes login, click here to view the full report on the Knowledge Center.